Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. Filosso, E. Ruffini, S. Asioli, L. Macrì, A. Oliaro (Torino, Italy). Adenosquamous (ADS) carcinoma of the lung: a subset with poor prognosis. Eur Respir J 2009; 34: Suppl. 53, 2688

Member's Comments

No comment yet.

Related content which might interest you: Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis Source: Eur Respir J 2008; 31: 854-859 Year: 2008 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Lymphoepithelioma-like carcinoma of the lung in a patient withsilicosis Source: Eur Respir J 2003; 22: 383-386 Year: 2003 Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Karyometric analysis of bronchioloalveolar carcinoma (BAC) and adenocarcinoma of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006 A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Pulmonary metastasis of a Merkel cell carcinoma (case report) Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Angiogenic squamous dysplasia: highly associated with squamous cell lung carcinoma Source: Annual Congress 2006 - Biological features, lung function and treatment of lung cancer Year: 2006 Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance. Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018 Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Trail receptors as prognostic factors in non-small cell lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Expression of D2-40 in small cell lung carcinomas (SCLC); Association with lymphatic invasion(L.I), clinical parameters and prognosis Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010